Display Settings:

Format

Send to:

Choose Destination
    Cancer Cell. 2009 Feb 3;15(2):148-59.

    mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.

    Source

    Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.

    Abstract

    mTOR complex 2 (mTORC2) contains the mammalian target of rapamycin (mTOR) kinase and the Rictor regulatory protein and phosphorylates Akt. Whether this function of mTORC2 is critical for cancer progression is unknown. Here, we show that transformed human prostate epithelial cells lacking PTEN require mTORC2 to form tumors when injected into nude mice. Furthermore, we find that Rictor is a haploinsufficient gene and that deleting one copy protects Pten heterozygous mice from prostate cancer. Finally, we show that the development of prostate cancer caused by Pten deletion specifically in prostate epithelium requires mTORC2, but that for normal prostate epithelial cells, mTORC2 activity is nonessential. The selective requirement for mTORC2 in tumor development suggests that mTORC2 inhibitors may be of substantial clinical utility.

    PMID:
    19185849
    [PubMed - indexed for MEDLINE]
    PMCID: PMC2701381
    Free PMC Article

    Images from this publication.See all images (5) Free text

    Figure 5
    Figure 4
    Figure 1
    Figure 3
    Figure 2

    Publication Types, MeSH Terms, Substances, Grant Support

    Publication Types

    MeSH Terms

    Substances

    Grant Support

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk